Regulatory Framework · 2.2 Access to Controlled Medicines

Partial compliance.

Mexico has verifiable national strategies to prevent and monitor shortages of medicines and health supplies. The strongest evidence comes from two official platforms: the Medicines and Health Supplies Procurement Monitoring Platform, which increases transparency over purchases, codes, units, suppliers, institutions, and procurement procedures; and the Medicines and Health Supplies Delivery Monitoring System, which tracks requests, deliveries, in-transit units, incomplete deliveries, and non-compliance, with filters by institution, federal entity, medicine, therapeutic group, and delivery status.

These tools are complemented by the 2025 National Compendium of Health Supplies, which structures institutional selection and provision, and by IMSS-BIENESTAR, which documents functions related to medicine catalogues, supply, inputs, and supervision in health facilities. Taken together, the evidence demonstrates a real national architecture for procurement and supply monitoring.

However, the indicator does not reach full compliance because the available evidence does not show that these mechanisms have homogeneously, sustainably, and verifiably prevented shortages across all states and health facilities. Gaps remain regarding outcomes, last-mile delivery, full supply continuity, and effective reduction of stockouts. At the subnational level, Mexico City, Puebla, and Oaxaca remain probatory gaps; Chiapas has contextual evidence of logistics routes and distribution in remote areas, but also reports persistent shortages. Therefore, Mexico shows important operational progress, but not fully effective and homogeneous shortage prevention under RC2 criteria.